CONDITION
Cholangiocarcinoma
Cholangiocarcinoma is a cancer that arises from the cells lining the bile ducts — the small tubes that carry bile from the liver to the intestine. It is uncommon in both dogs and cats, but when it does occur it tends to affect older animals. The tumour can develop within the liver itself or in the larger ducts outside the liver, and its behaviour varies with location and how far it has grown by the time it is found. Owners often notice signs that reflect disrupted bile flow or the space the tumour occupies: jaundice (a yellow tint to the gums, skin, or whites of the eyes), reduced appetite, weight loss, vomiting, or a quiet change in energy. Some animals show abdominal discomfort or a slightly distended belly. Because these signs overlap with many other liver and digestive conditions, the path to understanding what is happening typically involves blood tests, imaging, and sometimes sampling of tissue. This page explores what cholangiocarcinoma can look like in its early and later stages, what investigations help clarify the picture, how the tumour behaves over time, and what approaches exist when it is identified. The aim is to help you understand the condition, the questions that matter, and the shape of the road ahead.
Why this matters now
Cholangiocarcinoma tends to occur in older animals, most commonly in dogs and cats over eight years of age. No consistent breed predisposition has been established for cholangiocarcinoma. In cats, no breed link is documented (Persian cats are predisposed to a different, inflammatory condition — lymphocytic cholangitis/cholangiohepatitis — not to this cancer). In dogs, some case series suggest a possible predisposition in Labrador Retrievers and in females generally, but the rarity of the condition makes this difficult to confirm.
The cancer often grows silently within the bile ducts for weeks or months before signs become visible, and in many cases has already spread to surrounding liver tissue, lymph nodes, or distant organs by the time it is detected. The timeframe from first observable signs to more pronounced illness can be short — often a matter of weeks — though individual variation exists. Some animals may show subtle changes for a longer period before more obvious illness emerges, while others may decline more quickly once jaundice or weight loss appears.
Signals & patterns
Early signals
Reduced appetite or pickiness
An animal may begin leaving food in the bowl, eating smaller portions than usual, or showing less enthusiasm at mealtimes. This can be mild and intermittent at first, often attributed to normal variation or a change in routine.
Subtle weight loss
Weight may drop gradually over several weeks, sometimes noticeable only when the animal is weighed or when the ribs become easier to feel. In long-haired animals, this can be harder to spot by eye alone.
Quieter or less engaged behaviour
Some owners notice their pet becomes less interactive, sleeps more, or seems less interested in play or usual activities. The change can be subtle enough that it is only recognised in hindsight.
Occasional vomiting or nausea
Vomiting may occur sporadically, sometimes with no obvious pattern, and may initially be dismissed as a minor stomach upset. Nausea may also be inferred from lip-licking, drooling, or reluctance to eat.
Later signals
Jaundice
A yellow tint becomes visible in the gums, the whites of the eyes, or the skin inside the ears or on the belly. This occurs when bile cannot drain normally and bilirubin accumulates in the bloodstream, and is often the sign that prompts investigation.
Abdominal distension or discomfort
The abdomen may appear swollen or feel tense, sometimes due to fluid accumulation or an enlarged liver. Some animals become reluctant to be touched around the belly or may adopt a hunched posture.
Marked lethargy and weakness
Energy levels may drop noticeably, with the animal spending most of the day resting, showing little interest in food or interaction, and sometimes appearing reluctant to move or walk far.
Click to read about the biological mechanisms
How this is usually investigated
The investigation typically begins with a physical examination and a review of the history, looking for patterns in appetite, weight, behaviour, and any visible changes in colour of the gums or eyes. Blood work can reveal elevations in liver enzymes, bilirubin, and bile acids, which prompt closer scrutiny of the liver and bile ducts. Imaging allows the internal structure to be visualised, and tissue sampling provides the microscopic confirmation needed to distinguish cholangiocarcinoma from other liver masses or bile-duct disease.
Chemistry panel
Abdominal ultrasound
Computed tomography (CT)
Cytology
Histopathology
Options & trade-offs
Management is shaped by the extent of the tumour, the presence of metastasis, the animal's overall condition, and what is workable for the household. Most animals are not candidates for curative treatment by the time the diagnosis is made, and the focus often shifts to slowing progression, managing symptoms, and preserving comfort. Different combinations of approaches suit different animals and owners, and the picture can change as the disease evolves.
Surgical resection
If the tumour is localised to a portion of the liver that can be removed, surgery may be considered to excise the affected tissue. This approach is most relevant when imaging and exploratory findings suggest the cancer has not yet spread widely. The procedure involves removal of one or more liver lobes, and the remaining liver tissue can often compensate for the loss if the operation is successful.
Trade-offs: Surgery carries significant anaesthetic and procedural risk, particularly in animals with compromised liver function or poor body condition. Most cases of cholangiocarcinoma have already metastasised by the time of diagnosis, and even when a tumour appears resectable, microscopic spread may be present. Recovery requires careful monitoring, and the cancer may recur.
Chemotherapy
Systemic chemotherapy uses drugs that target rapidly dividing cells, with the aim of slowing tumour growth or reducing the burden of disease. Protocols vary, and treatment is typically administered in cycles over several weeks to months. Response rates in cholangiocarcinoma are generally modest, and the intent is often to extend time and improve quality of life rather than to cure.
Trade-offs: Side effects can include nausea, reduced appetite, and lowered white blood cell counts, requiring regular monitoring. The response to chemotherapy is unpredictable, and some animals may experience little benefit. The practicalities of repeated veterinary visits and the cost of the drugs and monitoring can be substantial.
Supportive care and symptom management
This approach centres on managing the consequences of bile-duct obstruction and liver dysfunction: anti-nausea medication, appetite stimulants, nutritional support, and monitoring for complications such as infection or clotting abnormalities. Fluid therapy and drugs to support liver function may be used as needed. The goal is to maintain comfort and function for as long as the disease allows.
Trade-offs: Supportive care does not slow the progression of the cancer itself, and the window during which an animal feels well can be limited. Some interventions require repeated visits or home administration of medication, and the balance between intervention and quality of life becomes a central consideration as the disease advances.
Palliative intent and monitoring
When curative or disease-modifying treatment is not pursued, attention turns to observing the animal's day-to-day experience and adjusting care to preserve comfort. This may involve minimal intervention, with treatment reserved for distressing symptoms. The focus is on quality rather than duration, and decisions are revisited as the animal's condition changes.
Trade-offs: This approach accepts that the disease will progress and that time is limited. It avoids the burdens of intensive treatment but requires careful attention to signs of discomfort or decline. The emotional weight of watching the disease advance without active intervention can be substantial for some owners.
Common misconceptions
"Jaundice always means the liver has failed completely."
Jaundice indicates that bilirubin is accumulating in the bloodstream, which can occur when bile flow is obstructed even if much of the liver tissue is still functioning. The liver retains considerable reserve capacity, and jaundice reflects a problem with bile drainage rather than total liver failure in many cases. The distinction matters when considering whether intervention is possible.
"If the tumour can be removed surgically, the cancer is cured."
Cholangiocarcinoma often spreads early, and microscopic metastases may already be present in tissue that appears normal on imaging or to the surgeon's eye. Even when a tumour is successfully excised, recurrence is common, and the time gained is variable. Surgery can extend life in some cases, but it is rarely curative in this type of cancer.
"Cholangiocarcinoma and other liver cancers respond equally well to treatment."
Different liver tumours have different biology and behaviour. Cholangiocarcinoma tends to be more aggressive and less responsive to chemotherapy than some other liver cancers, such as well-differentiated hepatocellular carcinoma. The prognosis and the likely response to treatment depend on the specific cell type, which is why histopathology is central to the diagnosis.
Related conditions
Bile Duct Obstruction
Cholangiocarcinoma can cause bile duct obstruction as the tumour grows within or compresses the bile ducts, preventing the normal flow of bile. In some cases, a dog or cat initially investigated for obstruction may be found to have an underlying malignancy rather than stones, inflammation, or stricture alone.
Cholangiohepatitis in Cats
Both conditions involve inflammation and damage to the bile ducts, and in cats with chronic or recurrent cholangiohepatitis, ongoing injury and repair of duct tissue may, in rare cases, create an environment in which malignant change becomes more likely over time. The early signs—jaundice, weight loss, altered liver enzymes—can overlap, and distinguishing the two often requires biopsy.
Hepatocellular Carcinoma
Hepatocellular carcinoma arises from the liver cells themselves rather than the bile duct lining, but both are primary liver cancers that can present with similar signs—jaundice, weight loss, elevated liver enzymes—and both require imaging and biopsy to distinguish them. The two conditions differ in their behaviour and tissue of origin, but owners may encounter both when researching liver tumours in dogs and cats.
Liver Disease in Dogs
Cholangiocarcinoma is one specific cause of liver disease, and many of the signs that bring an owner to investigate liver health—changes in blood work, jaundice, lethargy—are shared across a much broader range of liver conditions. Understanding the wider landscape of liver disease can help orient the questions asked during investigation and the context in which a diagnosis of cholangiocarcinoma sits.
Triaditis in Cats
Triaditis in cats involves concurrent inflammation of the bile ducts, pancreas, and intestine, and in cats with severe or chronic cholangiohepatitis as part of that pattern, there may be long-standing bile duct injury. While cholangiocarcinoma is uncommon, the overlap in clinical signs—jaundice, inappetence, weight loss—means that imaging and biopsy may be needed to distinguish inflammatory disease from neoplasia in some cases.
Because cholangiocarcinoma often affects older animals, it can exist alongside other age-related conditions that influence what is practical or tolerable. The Longevity & Healthspan pillar explores how multiple systems interact as animals age, and how different layers of illness shape the decisions that unfold. Understanding the trajectory of this cancer, the timeframes involved, and the shape of the options can help frame conversations about what matters most in the time that remains.